You are here » Home » Companies ยป Company Overview » Alembic Pharmaceuticals Ltd

Alembic Pharmaceuticals Ltd.

BSE: 533573 Sector: Health care
NSE: APLLTD ISIN Code: INE901L01018
BSE 00:00 | 07 Feb 524.60 -3.35
(-0.63%)
OPEN

529.40

HIGH

530.00

LOW

518.10

NSE 00:00 | 07 Feb 522.90 -5.40
(-1.02%)
OPEN

525.15

HIGH

529.45

LOW

518.30

OPEN 529.40
PREVIOUS CLOSE 527.95
VOLUME 4563
52-Week high 792.30
52-Week low 518.10
P/E 22.05
Mkt Cap.(Rs cr) 10,311
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 529.40
CLOSE 527.95
VOLUME 4563
52-Week high 792.30
52-Week low 518.10
P/E 22.05
Mkt Cap.(Rs cr) 10,311
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Alembic Pharmaceuticals Ltd. (APLLTD) - Chairman Speech

Company chairman speech

"Our journey has been heartening so far. I am looking forward toan even more exciting time in the years to come."

I consider myself extremely fortunate to be part of a business spacethat plays a pivotal role in improving health across the globe through its affordable andhigh- quality generic medicines no matter what. The multiple waves of the pandemic thatswept across the world further enhanced the capability and credibility of our businessspace.

The Indian pharmaceutical sector displayed commendable grit anddetermination in working overtime to overcome the significantly lethal second wave thatcaused a debilitating impact on lives and livelihood of Indians. Moreover India helpedmillions across the globe by sending its medicines to more than 100 nations.

This happened because the Indian pharmaceutical sector braved all oddsto ensure that medication was always close at hand. Alembic was a part of this covetedgroup. Our teams pulled out all stops to ensure that our medicines reached where theywere required on time. For this daunting effort I express my whole-hearted gratitude tothe entire Alembic team. It is owing to their patient perseverance and unwaveringdedication that the Company's respect among global and India peers has scaled a fewnotches higher.

Going forward

The world is looking up to India to take its rightful position as the'Medicine Box of the World'. But for that to happen India would need to make theconscientious climb up the value chain and build capabilities in new-age opportunities.

If the Indian pharmaceutical sector aims to rank among the Top 5nations in global pecking order and attain the podium position in volume terms it willneed to grow from about US$44 billion currently to US$120-130 billion by 2030 and US$500billion by 2047.

The Government is doing its part in creating an enabling ecosystem forthe pharmaceutical sector.

It recently introduced two PLI schemes which has generated considerableinterest. More recently in the Union Budget 2022 the Government has announced importantconfidence-enhancing measures and allocations which promise to provide significant impetusto the Indian Pharmaceutical sector.

But a lot more needs to be done with speed. For India to climb theglobal pecking order some important areas have come under its radar:

1) India will need to generate adequate skilled human capital byupgrading the curriculum of pharmaceutical studies to meet industry prerequisites.

2) India will need to nurture and drive innovative capabilities intocommercial success. And this can happen when it is able to integrate all stakeholders ofthe pharmaceutical and healthcare industry to push the industry to greater heights.

3) The Indian pharmaceutical sector will need to absorb and deployprevalent and relevant technologies such as AI Big Data Machine Learning IoT andanalytics. This I believe will help accelerate the pharma industry's vision of 'Make andDiscover in India'.

At Alembic we are firmly focused on making our operations digital. Forthis we have drawn the contours of a digital blueprint which will be implemented in aphased manner. We have reworked some bits of our R&D strategy to ensure that everyrupee is judiciously invested in the right areas. This will allow us to maximise the bangfrom every buck. Moreover with most of our capacity build-up in place we hope tomaximise returns from our investment in the years to come. This liquidity will then bedeployed to fuel our strategic initiatives which are aligned to sectoral demands.

Our journey has been heartening so far. I am looking forward to an evenmore exciting time in coming years. My aspiration is to build a robust institution thatgenerates pride in the minds of our stakeholders. I would love to come back and report toyou about our growth story in a year's time.

.